Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Solid Biosciences Inc (NASDAQ: SLDB) closed at $4.60 down -2.13% from its previous closing price of $4.70. In other words, the price has decreased by -$2.13 from its previous closing price. On the day, 1.04 million shares were traded. SLDB stock price reached its highest trading level at $4.7152 during the session, while it also had its lowest trading level at $4.5.
Ratios:
For a deeper understanding of Solid Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.20 and its Current Ratio is at 5.20. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on January 08, 2025, initiated with a Buy rating and assigned the stock a target price of $16.
On December 13, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $16.
On December 10, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $15.JMP Securities initiated its Mkt Outperform rating on December 10, 2024, with a $15 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 11 ’25 when Kahn Clare bought 1,860 shares for $5.34 per share. The transaction valued at 9,924 led to the insider holds 2,960 shares of the business.
Bain Capital Life Sciences Inv bought 1,000,000 shares of SLDB for $4,030,000 on Feb 19 ’25. The 10% Owner now owns 5,034,582 shares after completing the transaction at $4.03 per share. On Feb 19 ’25, another insider, PERCEPTIVE ADVISORS LLC, who serves as the Director of the company, bought 5,000,000 shares for $4.03 each. As a result, the insider paid 20,150,000 and bolstered with 11,833,539 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLDB now has a Market Capitalization of 356467808 and an Enterprise Value of 231724608.
Stock Price History:
The Beta on a monthly basis for SLDB is 1.98, which has changed by -0.66126657 over the last 52 weeks, in comparison to a change of 0.086116076 over the same period for the S&P500. Over the past 52 weeks, SLDB has reached a high of $15.05, while it has fallen to a 52-week low of $2.88. The 50-Day Moving Average of the stock is 7.02%, while the 200-Day Moving Average is calculated to be -25.15%.
Shares Statistics:
For the past three months, SLDB has traded an average of 2.42M shares per day and 1236460 over the past ten days. A total of 77.49M shares are outstanding, with a floating share count of 68.10M. Insiders hold about 12.13% of the company’s shares, while institutions hold 54.14% stake in the company. Shares short for SLDB as of 1740700800 were 7319778 with a Short Ratio of 3.03, compared to 1738281600 on 2651545. Therefore, it implies a Short% of Shares Outstanding of 7319778 and a Short% of Float of 11.41.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0